Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil

Clinical Endocrinology

Volumn 57, Issue 2, 2002, Pages 169-183

  Kaltsas, G A ^a   Mukherjee, J J ^a   Isidori, A ^a   Kola, B ^a   Plowman, P N ^a   Monson, J P ^a   Grossman, A B ^a   Besser, G M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ALPHA INTERFERON; ANTIBIOTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DIAZOXIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; LOMUSTINE; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; VINBLASTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CARCINOID; CHEMOTHERAPY INDUCED EMESIS; CHROMAFFIN CELL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; KAPLAN MEIER METHOD; LEUKOPENIA; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTOPENIA; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR REGRESSION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036375498     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01589.x     Document Type: Article

References (50)

1. Treatment of liver metastases of carcinoid tumors
2. Gastrointestinal endocrine tumours: Medical management
3. Treatment of neuroendocrine GEP tumours with somatostatin analogues: A review
4. Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine
5. Revised classification of neuroendocrine tumours of the lung, pancreas and gut
6. Carcinoid tumour
7. Nuclear medicine applications for neuroendocrine tumors
8. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
9. Tumor markers in neuroendocrine tumors
10. Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system
11. Medullary carcinoma of the thyroid: Diagnosis and therapy
12. Current diagnosis and management of medullary thyroid carcinoma
13. Clinical experience over 48 years with pheochromocytoma
14. Successful treatment by chemotherapy for acromegaly associated with ectopic growth hormone releasing hormone secretion from a carcinoid tumour
15. Chemotherapy for neuroendocrine tumors: The Beatson Oncology Centre experience
16. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma
17. Medullary thyroid carcinoma with multiple hepatic metastases: Treatment with transcatheter arterial embolization and percutaneous ethanol injection
18. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors
19. The role of chemotherapy in the non-surgical management of malignant neuroendocrine tumours
20. The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors
21. 5-Fluorouracil and lomustine (CCNU) combination for the treatment of advanced neuroendocrine tumours
22. Benign and malignant pheochromocytoma: Diagnosis, treatment, and follow-up
23. Reporting results of cancer treatment
24. An analysis of 8305 cases of carcinoid tumors
25. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome
26. The management of patients with advanced carcinoid tumors and islet cell carcinomas
27. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
28. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma
29. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome
30. Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome
31. 131I-MIBG
32. Long-term survival after diagnosis of hepatic metastatic VIPoma: Report of two cases with disparate courses and review of therapeutic options
33. Chemotherapy and biotherapy in neuroendocrine tumors
34. The use of chemotherapy in the management of neuroendocrine tumors
35. Advances in chemotherapy and biotherapy of endocrine tumors
36. Carcinoid tumors: Current concepts in diagnosis and treatment
37. Neuroendocrine gastrointestinal tumors - A condensed overview of diagnosis and treatment
38. State of the art and future prospects in the management of neuroendocrine tumors
39. Treatment of malignant carcinoid tumors: A randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon
40. Treatment of medullary thyroid carcinoma: An update
41. Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumours
42. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment
43. Chemotherapy in the treatment of neuroendocrine malignant tumors
44. Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin
45. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: A personal overview and concluding remarks
46. Management of pheochromocytoma
47. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract
48. Pancreatic endocrine tumours, immunotherapy and gene therapy: Chemotherapy and interferon therapy of endocrine tumours
49. Current approaches and perspectives in the therapy of medullary thyroid carcinoma
50. Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine